Learn More
Medchemexpress LLC N-(2-((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)met | 2254805-62-2 | 98.6% | C23H28ClN7O3S | 10MG

Supplier: Medchemexpress LLC HY13588710MG
ZX-29 is a potent, selective small-molecule anaplastic lymphoma kinase (ALK) inhibitor for research use. It inhibits wild-type ALK and key resistance mutants, induces endoplasmic reticulum stress and apoptosis, and can trigger protective autophagy with reported antitumor activity in preclinical studies.
- Potent ALK inhibition with low-nanomolar IC50s for wild-type and resistance mutants.
- Induces endoplasmic reticulum stress and apoptosis in cellular models.
- Promotes protective autophagy and demonstrates antitumor activity in preclinical assays.
- High reported purity (~98.6%) suitable for laboratory research.
- Soluble in DMSO (~50 mg/mL) with heating and sonication.
- Store protected from light; solvent stability varies by temperature.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.